Generate Biomedicines Q3 EPS $(0.68) Misses $(0.59) Estimate, Sales $4.220M Miss $7.750M Estimate

Generate Biomedicines (NASDAQ:GENB) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.59) by 15.25 percent. This is a 65.48 percent increase over losses of $(1.97) per share from the same period last year. The company reported quarterly sales of $4.220 million which missed the analyst consensus estimate of $7.750 million by 45.55 percent. This is a 56.20 percent decrease over sales of $9.634 million the same period last year.